Description: Abcam Plc distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. The company was founded by Adam Robert David Cleevely, Anthony Kouzarides and Jonathan Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.
Home Page: www.abcam.com
ABCM Technical Analysis
Discovery Drive
Cambridge,
CB2 0AX
United Kingdom
Phone:
44 12 2369 6000
Officers
| Name | Title |
|---|---|
| Mr. Alan Thomas Hirzel BS, M.B.A., M.S., MBA, MS | CEO & Exec. Director |
| Mr. Michael Shaun Baldock B.A. | CFO & Director |
| Mr. Mark Dermody | Interim CIO |
| James Staveley | VP of Investor Relations |
| Marc Perkins | Gen. Counsel & Company Sec. |
| Emma Sceats | Sr. VP of Sales, Service & Bus. Devel. |
| Mr. Nick Skinner | Sr. VP of HR |
| Mr. Mark Bushfield | Sr. VP of Research & Innovation |
| Ms. Kirstie Speck BBusSc | Head of Consumer Insights |
| Ms. Yvonne Chien | Sr. VP of Customer Experience |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 31.5457 |
|---|---|
| Trailing PE: | 207.5 |
| Price-to-Book MRQ: | 4.0028 |
| Price-to-Sales TTM: | 10.2269 |
| IPO Date: | 2010-12-03 |
| Fiscal Year End: | June |
| Full Time Employees: | 1682 |